Comment on "Bullous pemphigoid after anti-PD-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes''

被引：4

作者：

Apalla, Zoe ^{[1
]}

Lazaridou, Elizabeth ^{[1
]}

Lallas, Aimilios ^{[2
]}

机构：

[1] Aristotle Univ Thessaloniki, Sch Med, Dermatol Dept 2, Thessaloniki, Greece

[2] Aristotle Univ Thessaloniki, Sch Med, Dermatol Dept 1, Thessaloniki, Greece

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 06期

关键词：

D O I：

10.1016/j.jaad.2020.04.174

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E249 / E249

页数：1

共 4 条

[1] High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma [J].

Faje, Alexander T. ;

Lawrence, Donald ;

Flaherty, Keith ;

Freedman, Christine ;

Fadden, Riley ;

Rubin, Krista ;

Cohen, Justine ;

Sullivan, Ryan J. .

CANCER, 2018, 124 (18) :3706-3714

[2] Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology [J].

Feliciani, C. ;

Joly, P. ;

Jonkman, M. F. ;

Zambruno, G. ;

Zillikens, D. ;

Ioannides, D. ;

Kowalewski, C. ;

Jedlickova, H. ;

Karpati, S. ;

Marinovic, B. ;

Mimouni, D. ;

Uzun, S. ;

Yayli, S. ;

Hertl, M. ;

Borradori, L. .

BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (04) :867-877

[3]

Nelson CA, 2022, J AM ACAD DERMATOL, V87, P1399

[4] Early Use of Systemic Corticosteroids in Patients with Advanced NSCLC Treated with Nivolumab [J].

Scott, Susan C. ;

Pennell, Nathan A. .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) :1771-1775

← 1 →